BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Drug Development

  Innovation Pharmaceuticals Aims to Develop First Drug for Approval in Prevention of Oral Mucositis in Head and Neck Cancer Patients as Phase 2 Clinical Trial of Brilacidin Completes

  The final patient in the Phase 2 randomized, placebo-controlled clinical trial completed their post-therapy follow-up examination this week.

  October 26, 2017

   · 

  7 min read
• BioMidwest

  BioSig Technologies Announces Results of Independent Product Assessment Study for PURE EP System

  BioSig Technologies today announced that the Company has concluded a key part of the strategic planning project launched earlier this year in collaboration with Health Research International (HRI).

  October 26, 2017

   · 

  3 min read
• Deals

  Neos Therapeutics to Review Unsolicited Proposal From PDL BioPharma

  Neos Therapeutics, Inc. today confirmed that it has received an unsolicited proposal from PDL BioPharma, Inc. to acquire all of the outstanding shares of Neos for $10.25 per share in cash.

  October 26, 2017

   · 

  3 min read
• Business

  SeaSpine Announces Preliminary Results for Third Quarter 2017

  As of September 30, 2017, cash and cash equivalents are expected to be approximately $16.7 million

  October 26, 2017

   · 

  6 min read
• ENYO Pharma Opens a New Subsidiary in Australia as a New Managing Center for Clinical Trials

  Enyo Pharma made a strategic decision and has recently decided to open its first wholly owned subsidiary in Melbourne, Australia, because of its excellent clinical trials development capabilities and attractive conditions offered by the government.

  October 26, 2017

   · 

  2 min read
• Business

  Veracyte to Host Conference Call and Webcast to Discuss Third Quarter 2017 Financial Results on Monday, November 6, 2017

  Veracyte announced today that it will report its third quarter 2017 financial results after the close of market on Monday, November 6, 2017.

  October 26, 2017

   · 

  1 min read
• Business

  CohBar to Announce Third Quarter 2017 Financial Results and Host Conference Call for Shareholders on November 13, 2017

  The company will host a conference call for the shareholders at 2:00 p.m. PT the same day.

  October 26, 2017

   · 

  2 min read
• Business

  AIT Therapeutics Strengthens Executive Team with Three Key Senior Hires as Company Prepares for Upcoming Clinical Milestones

  Joining the Company are Giora Davidai, M.D. as Chief Medical Officer, Rhona Shanker as Director of Regulatory Affairs, and Professor Asher Tal, M.D. as Senior Vice President of Clinical Research.

  October 26, 2017

   · 

  5 min read
• Business

  UroGen Pharma Expands Leadership Team, Appoints Industry Veterans Jeffrey Bova as Vice President of Commercial and James Ottinger as Vice President of Regulatory Affairs

  The two new hires will report to UroGen’s CEO and will be based in the company’s New York office.

  October 26, 2017

   · 

  4 min read
• FDA

  Medinol Ltd. Receives CE Mark for the EluNIR Ridaforolimus-Eluting Coronary Stent System, and announces first commercial implantations

  Medinol announced that it obtained CE-mark for EluNIR, its novel Drug Eluting Stent featuring a unique stent design with low metal footprint and a proprietary elastomeric coating, both designed to optimize clinical outcomes.

  October 26, 2017

   · 

  3 min read